Autori: Bar-Or Amit
| Naslov | Safety and efficacy of fenebrutinib in relapsing multiple sclerosis (FENopta): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial and open-label extension study (Article) |
| Autori | Bar-Or Amit ... Drulovic Jelena S  ... (broj koautora 19)
|
| Info | LANCET NEUROLOGY, (2025), vol. 24 br. 8, str. 656-666 |
| Projekat | F. Hoffmann-La Roche |
| Ispravka | Web of Science Članak Elečas Rang časopisa |
     |
| Naslov | Fenebrutinib Maintains Low Disease Activity in Relapsing Multiple Sclerosis: Clinical, Safety and Biomarker Results From the FENopta Open-Label Extension (Meeting Abstract) |
| Autori | Bar-Or Amit Oh J Dufek Michal Budincevic Hrvoje Habek Mario Caunt Maresa Harp C Sierzega M Clayton David Chen Y Ratchford JN Goodyear Alexandra Drulovic Jelena S
|
| Info | MULTIPLE SCLEROSIS JOURNAL, (2025), vol. 31 br. 2_SUPPL, Suppl. 2_SUPPL, str. 244-244 |
| Ispravka | Web of Science Elečas Rang časopisa |
|
|
| Naslov | Fenebrutinib maintains low disease activity in relapsing multiple sclerosis: results from the FENopta trial open-label extension (Meeting Abstract) |
| Autori | Bar-Or Amit Oh Jiwon Dufek Michal Budincevic Hrvoje Habek Mario Caunt Maresa Thomas Piia Sierzega Malgorzata Clayton David Cheng Ying Fang Ratchford John Goodyear Alexandra Drulovic Jelena S
|
| Info | MULTIPLE SCLEROSIS JOURNAL, (2024), vol. 30 br. 3, Suppl. S, str. 1021-1022 |
| Ispravka | Web of Science Elečas Rang časopisa |
|
|
| Naslov | Cerebrospinal fluid and MRI analyses of fenebrutinib treatment in multiple sclerosis reveal brain penetration and early reduction of new lesion activity: results from the phase II FENopta study (Meeting Abstract) |
| Autori | Bar-Or Amit Dufek Michal Budincevic Hrvoje Drulovic Jelena S Habek Mario Hua Le Weber Martin Thomas Piia Napieralski Julie Clayton David Kuruvilla Denison Qi Qi Xu Yan Goodyear Alexandra Oh Jiwon
|
| Info | MULTIPLE SCLEROSIS JOURNAL, (2023), vol. 29 br. , Suppl. 3, str. 1049-1050 |
| Projekat | F. Hoffmann-La Roche Ltd |
| Ispravka | Web of Science Elečas Rang časopisa |
|
|
| Naslov | Efficacy and Safety of Fenebrutinib, a Noncovalent, Reversible BTK inhibitor, in MS: Primary Results of a Phase 2 Trial (Meeting Abstract) |
| Autori | Hua Le Bar-Or Amit Weber Martin Habek Mario Budincevic Hrvoje Thomas Piia Napieralski Julie Ratchford John Qi Qi Sierzega M Drulovic Jelena S
|
| Info | EUROPEAN JOURNAL OF NEUROLOGY, (2023), vol. 30 br. , Suppl. 1, str. - |
| Ispravka | Web of Science Elečas Rang časopisa |
|
|
